Incremental Value of CSF Biomarkers in Clinically Diagnosed AD and Non-AD Dementia
Sign Up to like & getrecommendations! Published in 2020 at "Frontiers in Neurology"
DOI: 10.3389/fneur.2020.00560
Abstract: Background: Cerebrospinal fluid (CSF) biomarkers are used to diagnose Alzheimer disease (AD), especially in atypical clinical presentations. No consensus currently exists regarding cut-off values. This study aimed, firstly, to define optimal cut-off values for CSF… read more here.
Keywords: incremental value; csf biomarkers; csf; cut values ... See more keywords